[North Carolina] Panel passes embryonic stem cell research
By Gary D. Robertson,
Associated Press
| 07. 26. 2007
RALEIGH (AP) - The largest committee in the state House backed legislation Thursday setting rules for how research can be performed on human embryonic stem cells, even though the bill eliminated funding to encourage research.
The bill's primary sponsor is Rep. Earl Jones, D-Guilford.
The guidelines, approved by a 45-35 vote, would permit research on stem cells left over from in-vitro fertilization that would otherwise be discarded. But a $10 million appropriation was removed from the bill that would have helped the state Health and Wellness Trust Fund distribute grants to nonprofit groups conducting stem cell research.
The money was eliminated because it could take about a year for the trust fund to set up guidelines, Jones said. He said embryonic stem cells could offer a renewable source of replacement cells and tissues to treat Parkinson's and Alzheimer's diseases, spinal cord injuries and other conditions.
"People are dying from these diseases," said Rep. Larry Womble, D-Forsyth, who supports the bill. "If we can address that to save a whole lot of lives that we cannot save now ... this is...
Related Articles
By Katherine Long, Ben Foldy, and Lingling Wei, The Wall Street Journal | 12.13.2025
Inside a closed Los Angeles courtroom, something wasn’t right.
Clerks working for family court Judge Amy Pellman were reviewing routine surrogacy petitions when they spotted an unusual pattern: the same name, again and again.
A Chinese billionaire was seeking parental...
By David Jensen, The California Stem Cell Report | 12.11.2025
California’s stem cell and gene therapy agency today approved spending $207 million more on training and education, sidestepping the possibility of using the cash to directly support revolutionary research that has been slashed and endangered by the Trump administration.
Directors...
By Sarah Kliff, The New York Times | 12.10.2025
Micah Nerio had known since his early 30s that he wanted to be a father, even if he did not have a partner. He spent a decade saving up to pursue surrogacy, an expensive process where he would create embryos...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
